Study drug for aggressive brain tumor after surgery
Part of Cancer clinical trials.
This trial tests an “antisecretory factor” treatment in people with grade 4 glioblastoma (or astrocytoma). It aims to see whether it can improve outcomes when used alongside planned cancer treatments after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed by pathology with glioblastoma or astrocytoma grade 4
- You are between 18 and 75 years old
- You had surgery with tumor removal (resection), not just a small sample
- Your treatment plan includes chemotherapy with radiation, or chemotherapy alone (not radiation only)
- You can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if Salovum, a special egg yolk product, can improve oxygen levels and reduce pressure and inflammation in the brain for people with a suspected glioblastoma. It involves a biopsy before treatment starts.
This trial tests whether two special food products (Salovum and SPC Flakes) can help reduce brain swelling caused by tumors. If you have a brain tumor with swelling and are already on steroids, you may be able to join.
This trial tests a more intense chemotherapy plan for people with glioblastoma who had only partial removal of their tumor or whose tumor grew back quickly. The goal is to see if this approach can improve outcomes.
This trial tests a special MRI technique to help surgeons remove more of a glioblastoma brain tumor during surgery. The goal is to see if this approach helps people live longer.
This early-stage trial tests whether a new oral medication called gallium maltolate can help slow or shrink glioblastoma (a serious brain tumor) that has come back after initial treatment. The study enrolls patients who have already had standard brain tumor treatment and whose tumors are growing again.
This Phase 1/2 study tests whether “glutamate inhibitor” medications can be safely added for newly diagnosed glioblastoma, and how they affect treatment outcomes. It’s designed for adults who will also receive the standard chemo‑radiation plan with temozolomide.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.